
Chromadex Corp
NASDAQ:CDXC

Intrinsic Value
The intrinsic value of one
CDXC
stock under the Base Case scenario is
3.1
USD.
Compared to the current market price of 7.74 USD,
Chromadex Corp
is
Overvalued by 60%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Chromadex Corp
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Chromadex Corp
Balance Sheet Decomposition
Chromadex Corp
Current Assets | 64.1m |
Cash & Short-Term Investments | 44.5m |
Receivables | 7.8m |
Other Current Assets | 11.8m |
Non-Current Assets | 4.2m |
PP&E | 3.4m |
Intangibles | 359k |
Other Non-Current Assets | 368k |
Free Cash Flow Analysis
Chromadex Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Chromadex Corp
Revenue
|
99.6m
USD
|
Cost of Revenue
|
-38m
USD
|
Gross Profit
|
61.6m
USD
|
Operating Expenses
|
-53.9m
USD
|
Operating Income
|
7.7m
USD
|
Other Expenses
|
824k
USD
|
Net Income
|
8.6m
USD
|
CDXC Profitability Score
Profitability Due Diligence
Chromadex Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
Chromadex Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
CDXC Solvency Score
Solvency Due Diligence
Chromadex Corp's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

Score
Chromadex Corp's solvency score is 89/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CDXC Price Targets Summary
Chromadex Corp
Dividends
Current shareholder yield for CDXC is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CDXC
stock under the Base Case scenario is
3.1
USD.
Compared to the current market price of 7.74 USD,
Chromadex Corp
is
Overvalued by 60%.